It is now well known that the binding of p53 to its DNA response elements is strongly correlated with its biological function, and many tumorigenic mutants lead to loss of both DNA binding and tumor suppressor function. A recent cocrystal structure of a minimal core p53 DNA binding domain peptide (p53DBD) complexed with a DNA response element has provided valuable insights into the binding specificity of p53. However, many important questions remained unanswered. We have carried out extensive chemical footprinting, cross-linking and DNA cyclization experiments on the complex between wild-type p53DBD and the Waf1 response element. Waf1 is a response element of considerable interest since its gene product, the p21 protein, inhibits CDK function, leading to cell cycle arrest at the G1/S phase boundary. The results show that four p53DBD bind to the major groove of the 20 base pair Waf1 response element, with each peptide bound to a pentameric quarter-site in a staggered array such that the peptides are oriented in the same direction. Molecular modeling studies using crystallographic coordinates for the p53DBD peptide and the protein-DNA contacts recently identified show that severe steric clashes occur when the peptides are bound to straight DNA, but are effectively relieved when the response element DNA bend approximately 50 degrees. This result has not been previously observed in regulatory nucleoprotein complexes and has important implications for the sequence specificity of p53 binding. An important component of the DNA binding properties of p53 is the tetramerization of the active protein. A complete structure of the core tetramerization domain of wild-type p53 has been obtained. This domain has a novel, antiparallel structure that appears to permit interactions of the basic C-terminal tail with the p53DBD, thereby modulating the DNA sequence specificity and binding affinity of wild-type p53. The p53 tetramerization domain is located in the C-terminal region of the protein. This region is phosphorylated at several serines, suggesting that phosphorylation may be an important regulator of p53 function. To determine if phosphorylation affects tetramer formation, we synthesized phosphopeptides corresponding to the C-terminal region of p53 and found that phosphorylation at Ser392 increased the association constant for tetramer formation nearly 10-fold. These results suggest that phosphorylation at Ser392 may modulate the affinity of tetramers, most probably between the C-terminal residues and the region immediately adjacent to Ser315.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005599-06
Application #
2463653
Study Section
Special Emphasis Panel (LCB)
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Mittelstadt, Paul R; Yamaguchi, Hiroshi; Appella, Ettore et al. (2009) T cell receptor-mediated activation of p38{alpha} by mono-phosphorylation of the activation loop results in altered substrate specificity. J Biol Chem 284:15469-74
Bang, Jeong; Yamaguchi, Hiroshi; Durell, Stewart R et al. (2008) A small molecular scaffold for selective inhibition of Wip1 phosphatase. ChemMedChem 3:230-2
Shi, Xiaobing; Kachirskaia, Ioulia; Yamaguchi, Hiroshi et al. (2007) Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol Cell 27:636-46
Demidov, O N; Kek, C; Shreeram, S et al. (2007) The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis. Oncogene 26:2502-6
Di Lello, Paola; Jenkins, Lisa M Miller; Jones, Tamara N et al. (2006) Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol Cell 22:731-40
Schito, Marco L; Demidov, Oleg N; Saito, Shin'ichi et al. (2006) Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation. J Immunol 176:4818-25
Shreeram, Sathyavageeswaran; Demidov, Oleg N; Hee, Weng Kee et al. (2006) Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol Cell 23:757-64
Dudgeon, Crissy; Kek, Calvina; Demidov, Oleg N et al. (2006) Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgene. Cancer Res 66:2928-36
Higashimoto, Yuichiro; Asanomi, Yuya; Takakusagi, Satoru et al. (2006) Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer. Biochemistry 45:1608-19
Chao, Connie; Wu, Zhiqun; Mazur, Sharlyn J et al. (2006) Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol Cell Biol 26:6859-69

Showing the most recent 10 out of 31 publications